Medication "While primary care physicians may still follow the old idea that metformin is 'first line,' I think most endocrinologists have been using GLP-1 receptor agonists and SGLT2 inhibitors as best-in-class therapy for nearly a decade," says Michael Uzmann, MD, a dual board-certified endocrinologist and internist at A1Endocrinology in Las Vegas
Biomedicines 11, 292
PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies, accessible in all 50 states without insurance or membership fees
Currently in clinical development by Eli Lilly, retatrutide earned the nickname triple G because it mimics the action of three key metabolic hormones: GLP-1, GIP, and glucagon
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials